Labcorp (LH) – Press Releases
-
Labcorp Announces 2024 First Quarter Results
-
Labcorp Announces Winning Bid for Select Assets of Invitae
-
Invitae Enters into Agreement with Labcorp for Sale of Business
-
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
-
Labcorp Declares Quarterly Dividend
-
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
-
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
-
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
-
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research
-
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
-
The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab
-
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
-
Labcorp to Announce First Quarter Financial Results on April 25, 2024
-
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials
-
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer
-
Labcorp Launches Weight Loss Management Testing Solutions
-
PINNACLE FERTILITY PARTNERS WITH LABCORP TO ENHANCE GENETIC TESTING SERVICES
-
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
-
Labcorp Announces 2023 Fourth Quarter and Full Year Results
-
Labcorp Elevates Employee Health Benefits with WeightWatchers for Business Full-Spectrum Weight Health Platform
-
Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine
-
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
-
Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
-
Labcorp Declares Quarterly Dividend
-
Labcorp and Hawthorne Effect Collaborate to Bring Clinical Trials Directly to Patients and Investigators in Local Communities
-
Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
-
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures
-
SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
-
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
-
Labcorp and Legacy Health Finalize Comprehensive Laboratory Relationship
-
Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments
-
Geneoscopy Signs Multi-Year Agreement with Labcorp to Distribute Noninvasive Multi-Target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
-
Ovia Health Unveils New Fertility and Family Building Benefit
-
Labcorp Announces 2023 Third Quarter Results
-
Labcorp Declares Quarterly Dividend
-
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
-
LABCORP AND BAYSTATE HEALTH ANNOUNCE STRATEGIC RELATIONSHIP FOR DIAGNOSTIC LABORATORY SERVICES
-
Labcorp to Announce Third Quarter Financial Results on October 26, 2023
-
Graves Gilbert, Circuit Clinical, and Labcorp Join Forces to Bring Clinical Trials to Patients across South Central Kentucky
-
Labcorp to Present Strategy, Business and Financial Outlook at Investor Day
-
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
-
Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business
-
Labcorp to Host Investor Day on September 14, 2023
-
Labcorp Announces 2023 Second Quarter Results
-
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
-
Labcorp OnDemand Offers Menopause Test to Consumers
-
Labcorp Finalizes Strategic Relationship with Jefferson Health
-
Labcorp Declares Quarterly Dividend
-
LABCORP AND LEGACY HEALTH AGREE TO COMPREHENSIVE LABORATORY RELATIONSHIP
-
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
Back to LH Stock Lookup
